Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D0CA2S
|
||||
Former ID |
DIB009287
|
||||
Drug Name |
HYDAMTIQ
|
||||
Synonyms |
PARP-1 inhibitor (brain ischemia), University of Perugia
|
||||
Indication | Brain ischaemia [ICD9: 435, 437; ICD10:G45.9, I67.8] | Investigative | [543709] | ||
Company |
Universita di Perugia
|
||||
Structure |
Download2D MOL |
||||
Canonical SMILES |
C(N(C)C)c1cc2c3c(cccc3c(=O)[nH]c2s1)O
|
||||
Target and Pathway | |||||
Target(s) | Poly [ADP-ribose] polymerase-1 | Target Info | Inhibitor | [543709] | |
KEGG Pathway | Base excision repair | ||||
NF-kappa B signaling pathway | |||||
PANTHER Pathway | FAS signaling pathway | ||||
Pathway Interaction Database | Integrin-linked kinase signaling | ||||
Caspase Cascade in Apoptosis | |||||
Notch-mediated HES/HEY network | |||||
Reactome | Dual Incision in GG-NER | ||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.